Functionality of the Nagoya ABS Protocol with a view to AnGR and a side-look to Anti- Conterfeiting Trade Agreement (ACTA)

Similar documents
Common Pools in Aquaculture Sui Generis and Other Options for Benefit Sharing

Convention on Biological Diversity: ABS. The Nagoya Protocol on Access and Benefit-sharing

The Nagoya Protocol. Overview of the Nagoya Protocol

NAGOYA PROTOCOL ON ACCESS TO GR AND BENEFIT SHARING (ABS): CHALLENGES AND OPPORTUNITIES FOR MICROBIOLOGY DR. ALEJANDRO LAGO CANDEIRA

Note by the Executive Secretary

Art Glowka ( )

CBD/ Access and Benefit Sharing

Intellectual Property and Genetic Resources: Relationship with Relevant International Instruments

JBA ABS Symposium on Digital Sequence Information. 28 February 2018 Tokyo

BioTrade and the Implementation of the Nagoya Protocol

The Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits arising from their Utilization

Genetic Resources and Intellectual Property: Recent developments under the Convention on Biological Diversity

Committee on Development. for the Committee on the Environment, Public Health and Food Safety

Subregional Seminar on the Legal Protection of Biotechnology and Genetic Resources Banska Bystrica, May 2 and 3, Access and Benefit Sharing

DERIVATIVES UNDER THE EU ABS REGULATION: THE CONTINUITY CONCEPT

II. SCOPE III. MAIN COMPONENTS... 21

CBD Request to WIPO on the Interrelation of Access to Genetic Resources and Disclosure Requirements

Søren Flensted Lassen, Novozymes A/S 07 June 2016

The BBNJ instrument could also restate the objective of UNCLOS to protect and preserve the marine environment.

WIPO Intergovernmental Committee on Intellectual Property, Genetic Resources, Traditional Knowledge and Folklore, Sixth Session, March 2004

Different Options for ABS in Relation to Marine Genetic Resources in ABNJ

Building TRUST Literally & Practically. Philippe Desmeth World Federation for Culture Collections

CBD. Distr. GENERAL. UNEP/CBD/COP/9/INF/16 4 March 2008 ENGLISH ONLY

Access and Benefit Sharing (Agenda item III.3)

BIOPIRACY: FACT OR FICTION? INTERNATIONAL TREATY NEGOTIATIONS COULD AFFECT YOUR IP RIGHTS AND YOUR BOTTOM LINE

The Nagoya Protocol: Compliance. Implications of the E.U. law for Microbiologists

Access and benefit- sharing information kit. Ivan Cholakov Gostock/Shutterstock

Question Q 159. The need and possible means of implementing the Convention on Biodiversity into Patent Laws

TRIPS, FTAs and BITs: Impact on Domestic IP- and Innovation Strategies in Developing Countries

Norwegian Nature Diversity Act - Genetic Material

CHAPTER IV TRIPS VERSUS CBD: TOWARDS A FRAMEWORK FOR INTELLECTUAL PROPERTY PROTECTION OF BIODIVERSITY

Multilateral negotiations on IP - Traditional Knowledge and Genetic resources

Statement by the BIAC Committee on Technology and Industry on THE IMPACT OF INTELLECTUAL PROPERTY PROTECTION ON INNOVATION AND TECHNOLOGY DEVELOPMENT

Law. Environment and Development Journal

19 Progressive Development of Protection Framework for Pharmaceutical Invention under the TRIPS Agreement Focusing on Patent Rights

South-South Exchange Meeting on the Conservation and Sustainable Use of Forest Biodiversity, 8-10 July 2009

Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore

Standing Committee on the Law of Patents

General Overview: Objectives, Principles and Achievements to date of the current Programme of Work on Traditional Knowledge

Flexibilities in the Patent System

THE ASEAN FRAMEWORK AGREEMENT ON ACCESS TO BIOLOGICAL AND GENETIC RESOURCES

African Union Practical Guidelines for the Coordinated Implementation of the Nagoya Protocol in Africa

The 45 Adopted Recommendations under the WIPO Development Agenda

Legal Status of Marine Genetic Resources in the Context of BBNJ Negotiations: Diverse Legal Regimes and Related Problems

B) Issues to be Prioritised within the Proposed Global Strategy and Plan of Action:

Sectoral Linkages and Lessons Learnt on Access and Benefit Sharing (ABS): Moving the ABS Agenda Forward

Convention on Biological Diversity: ABS. Theme Traditional knowledge

Standing Committee on the Law of Patents Twenty-Sixth Session

BIOBASED PRODUCTS AND POTENTIAL IMPACTS OF THE NAGOYA PROTOCOL

Establishing a Development Agenda for the World Intellectual Property Organization

Exhaustive Training module for new Patent examiners

Protecting Intellectual Property under TRIPS, FTAs and BITs: Conflicting Regimes or Mutual Coherence?

WIPO Development Agenda

Role of Patents in Green Technology Transfer in the Context of Climate Change

WIPO NATIONAL WORKSHOP FOR PATENT LAWYERS

An overview of India's approach to key IP issues at home and abroad. Dr. Bona Muzaka King s College London

Standing Committee on the Law of Patents

IPRs and Public Health: Lessons Learned Current Challenges The Way Forward

p. 21 p. 45 p. 87 p. 89

Anita Pissolito Campos Nascimento & Mourão Advogados. Anita Pissolito Campos Nascimento e Mourão Advogados

Marine biological diversity of areas beyond national jurisdiction. Legal and policy framework

LAW ON TECHNOLOGY TRANSFER 1998

SHORT SUMMARY REPORT OF THE WORKSHOP ON GENETIC INVENTIONS, INTELLECTUAL PROPERTY RIGHTS AND LICENSING PRACTICES

Presented at GIZ/SAWTEE Training on IPR 1-2 March 2012, Laltipur. Ratnakar Adhikari South Asia Watch on Trade, Economics and Environment

WIPO s work on disclosure and protection of TK & GR Introduction in the Draft Provisions on TK and Revised List of Options on GR

COMPLIANCE OF CANADA S UTILITY DOCTRINE WITH INTERNATIONAL MINIMUM STANDARDS OF PATENT PROTECTION

Convention on Biological Diversity: ABS. Theme The Bonn Guidelines

Dr. Biswajit Dhar Professor, Jawaharlal Nehru University, India and Member DA9 Advisory Board

Standing Committee on TRIPS Standing Committee on IP and Genetic Resources / Traditional Knowledge

DRAFT GUIDELINES ON ACCESS AND BENEFIT SHARING

5 th Annual Pharma IPR Conference 2016

10th Pan African Workshop on Access and Benefit-Sharing

Intellectual Property

CBD. Distr. GENERAL. CBD/DSI/AHTEG/2018/1/4 20 February 2018 ENGLISH ONLY

The relationship between the IR, the WTO, UPOV Convention and WIPO. Jorge Cabrera Medaglia

USTR NEWS UNITED STATES TRADE REPRESENTATIVE. Washington, D.C UNITED STATES MEXICO TRADE FACT SHEET

WIPO-WTO Colloquium for Teachers of Intellectual Property


TRAINING SEMINAR PHARMACEUTICALS AND INTELLECTUAL PROPERTY ACCESS TO MEDICINE: Exploitation of pharmaceutical patents: compulsory licences SESSION 4

Questionnaire February 2010

Animal Genetic Resources and Intellectual Property Rights The Issues

GENEVA WIPO GENERAL ASSEMBLY. Thirty-First (15 th Extraordinary) Session Geneva, September 27 to October 5, 2004

372 index. predominantly for supply of domestic market 113, 132 3, 184 5, 186; remedying anticompetitive

WTO-ESCAP-IIUM Regional Workshop on IP and Public Health and Environment Policy for Asian and Pacific Region

Item 7.4 of the Provisional Agenda SEVENTH SESSION OF THE GOVERNING BODY. Kigali, Rwanda, 30 October - 3 November 2017

BIPF Munich. South Africa Enforcement of Pharmaceutical Patents and the New Draft IP Policy

SAUDI ARABIAN STANDARDS ORGANIZATION (SASO) TECHNICAL DIRECTIVE PART ONE: STANDARDIZATION AND RELATED ACTIVITIES GENERAL VOCABULARY

Americas Trade and Sustainable Development Forum (ATSDF) November 2003, Miami. Trade, Knowledge and Intellectual Property Rights Thematic Tent

Settlement of Pharma Disputes and Competition Law in Korea

Intellectual Property: Plurality, Culture, National Interest, and International Harmonization

Access and Benefit Sharing: Case studies and International experience

INTELLECTUAL PROPERTY OVERVIEW. Patrícia Lima

PROTECTION OF INTELLECTUAL PROPERTY

Yearly Planner for PG Diploma in IPR (PGDIPR)

Yearly Planner for 4 th Batch of PG Diploma in IPR (PGDIPR) Course

IP Reserch and Use of IP Case Studies for Educational Purposes: Views and Challenges Geneva, April 26-29, 29, 2011

ECONOMIC PARTNERSHIP AGREEMENT BETWEEN THE CARIFORUM STATES, OF THE ONE PART, AND THE EUROPEAN COMMUNITY AND ITS MEMBER STATES, OF THE OTHER PART

Charles Lawson * INTRODUCTION

THE LABORATORY ANIMAL BREEDERS ASSOCIATION OF GREAT BRITAIN

University of Asia Pacific (UAP) Department of Law and Human Rights

Transcription:

Functionality of the Nagoya ABS Protocol with a view to AnGR and a side-look to Anti- Conterfeiting Trade Agreement (ACTA) Morten Walløe Tvedt Senior research fellow International Technical Expert Workshop AnGR ABS, 8. 10. December 2010 Original paper FNI Report 9/2010 with Olivier Rukundo, llm law December 9 th 2010, International Technical Expert Workshop

Relevant projects: Animal Genetic Resources: Process Patent Protection in the Field of Animal Breeding and Farm Animal Genetic Resources (In co-operation with Magnus Finckenhagen, 2008) Patenting in the Field of Animal Breeding and Animal Genetic Resources (2008) Vageningen FAO project about AnGR: Animal Genetic Resources Exchange, Conservation and Sustainable Use Policy and Regulatory Options (January 2007); Aquatic and Marine Genetic Resource: Ongoing projects on Aquatic Genetic Resources (Marine Biobank, Norway and India) Access to and Property Rights of Aquaculture Genetic Resources Norwegian Perspectives (The Journal of World Intellectual Property (2006) Vol. 9, no. 4, pp. 392 412) Bioprospecting and the Convention on Biological Diversity: Functionality of an ABS Protocol before the 2th Montreal Meeting Genetic resources in the CBD the wording, the past, the present and the future (2010 with Peter Johan Schei) Beyond Access Options for implementing CBD in User Countries (2007 with Tomme R. Young) Elements for Legislation in User Countries to Meet the Fair and Equitable Benefit-Sharing Commitment (The Journal of World Intellectual Property (2006) Vol. 9, no. 2, pp. 189 212) International Patent Law and Genetic Resources: One Worldwide Patent System: what's in it for developing countries? (Third World Quarterly 2010) A Path to One Universal Patent (Journal of Environmental Policy and Law 2008) How will the new WIPO draft Substantive Patent Law Treaty affect Genetic Resources? (Journal of World Intellectual Property 2005 no 3 May);

FNI s ABS Project Team Regine Andersen Peter Johan Schei Kristin Rosendal Morten Walløe Tvedt Ole Kristian Fauchald Tone Winge

ABS Publications: Functionality of an ABS Protocol, Morten Walløe Tvedt and Olivier Rukundo, 9/2010 Cameroon Case studies of ABS, FNI Reports 8 & 10/2010 Analytical tools for ABS cases studies, Kristin Rosendal. FNI Report 7/2010 Genetic Resources in the CBD The Wording, the Past, the Present and the Future, Peter Johan Schei and Morten Walløe Tvedt, FNI Report 4/2010 International Agreements and Processes Affecting an International Regime on Access and Benefit Sharing under the Convention on Biological Diversity Implications for its Scope and Possibilities of a Sectoral Approach, Regine Andersen, Morten Walløe Tvedt, Ole Kristian Fauchald, Tone Winge, Kristin Rosendal and Peter Johan Schei, FNI Report 3/ 2010 Balancing Building Blocks of a Functional ABS System, Tomme R. Young and Morten Walløe Tvedt, FNI Report 7/2009

Background for studying functionality: Original study-object the draft protocol before the second resumed meeting. The topic is to analyse the functionality of the draft with respect for the whether it is likely to contribute to the fair and equitable benefit sharing Combine existing law with the draft Consider consequences, possible and obstacles This paper: the Nagoya Protocol, with the aim of combining the Protocol with insight in AnGR for the purpose of identifying legal functionality

Legal functionality: Reflection upon potential for a legal system to contribute to defined objectives In ABS: Balance between providing rules and user obligations 1) creating incentives for users to enter into such contracts, and 2) making such contracts enforceable in the jurisdictions where the genetic resources are being used Trigger point and end point for the obligation for benefit sharing

Topics for the analises: Relationship of the Nagoya Protocol and other legal instruments for AnGR Scope-related issues relevant for AnGR Utilisation of GR as trigger-point for obligations Pathogens the unresolved complex

Other international instruments general I Art 3 bis 4. THIS PROTOCOL IS THE INSTRUMENT FOR THE IMPLEMENTATION OF THE ACCESS AND BENEFIT-SHARING PROVISIONS OF THE CONVENTION. [...] Observations: Takes a general point of departure and setting the general norm Includes ABS for AnGR It is however an open question to what extent exchange of AnGR will be covered from a practical point of view

Other int. instruments general II Art 3 bis 4. [...] WHERE A SPECIALISED INTERNATIONAL ACCESS AND BENEFIT-SHARING INSTRUMENT APPLIES THAT IS CONSISTENT WITH, AND DOES NOT RUN COUNTER TO THE OBJECTIVES OF THE CONVENTION AND THIS PROTOCOL, THIS PROTOCOL DOES NOT APPLY FOR THE PARTY OR PARTIES TO THE SPECIALISED INSTRUMENT IN RESPECT OF THE SPECIFIC GENETIC RESOURCE COVERED BY AND FOR THE PURPOSE OF THE SPECIALISED INSTRUMENT. Observations: General exception for specialised international abs instruments: potential for an AnGR instrument Recognises special sectoral needs Keeps the door open both for existing and new instruments Limitation: DOES NOT RUN COUNTER Flexible: targets only the resources under the other agreement Creates grey-zones at the point of time of access as does the IT

Other international instruments - past Art 3 bis 1. The provisions of this Protocol shall not affect the rights and obligations of any Party deriving from any existing international agreement, except where the exercise of those rights and obligations would cause a serious damage or threat to biological diversity. This paragraph is not intended to create a hierarchy between this Protocol and other international instruments. Observations: Time perspective backwards: existing rights and obligations in int. law The question is whether there are situations where the exercise of those rights and obligations would cause a serious damage or threat to biological diversity? Somewhat contradictory: not affect rights and obligations not create hierarchy

Other international instruments - present Art 3 bis 3. This Protocol shall be implemented in a mutually supportive manner with other international instruments relevant to this Protocol. Due regard should be paid to useful and relevant ongoing work or practices under such international instruments and relevant international organizations, provided that they are supportive of and do not run counter to the objectives of the Convention and this Protocol. Observations: Time perspective forwards: Implementation mutually supportive Ongoing work and practices What is meant by: Due regard should be paid to useful and relevant ongoing work or practices? Work and practices supportive of... CBD

Other international instruments future Art 3 bis 2. Nothing in this Protocol shall prevent the Parties from developing and implementing other relevant international agreements, including other specialised access and benefit-sharing agreements, provided that they are supportive of and do not run counter to the objectives of the Convention and this Protocol. Observations: General exception for specialised international ABS instruments: potential for an AnGR instrument Recognises the special sectoral needs Keeps the door open for new instruments (does not mean that there is a need for such instruments)

Observations: Scope related issues to AnGR ARTICLE 3 SCOPE 1. This Protocol shall apply to genetic resources within the scope of Article 15 of the Convention and to the benefits arising from the utilization of such resources. This Protocol shall also apply to traditional knowledge associated with genetic resources within the scope of the Convention and to the benefits arising from the utilization of such knowledge. AnGR are covered Scope-related issues were far more complicated in the draft before Nagoya (that were acquired after the entry into force of this Protocol for a Party with Parties providing such resources)

Special considerations Art 6 In the development and implementation of its access and benefitsharing legislation or regulatory requirements, each Party shall: [...] (c) Consider the importance of genetic resources for food and agriculture and their special role for food security. Observations: Basis in the Nagoya Protocol for implementing national special legislation for AnGR Potential to develop an AnGR-guideline for national implementation Issue for discussion: Perhaps a guideline will be more fruitful and functional than a treaty?

Observations: Utilisation for AnGR Art 2 (c) Utilization of genetic resources means to conduct research and development on the genetic and/or biochemical composition of genetic material, including through the application of biotechnology as defined in Article 2 of the Convention. Finally attention given to utilisation as a trigger point for benefit sharing The access-point of time failure of ABS The interesting issue to explore is how this understanding of utilisation is made operative in the Protocol Functional for AnGR?

Utilisation in context Art 2 (e) Derivative means a naturally occurring biochemical compound resulting from the genetic expression or metabolism of biological or genetic resources, even if it does not contain functional units of heredity. Observations: Wide definition Relevant for AnGR as a broad set of products will be convered

Observations: Utilisation in context ARTICLE 12 COMPLIANCE WITH DOMESTIC LEGISLATION OR REGULATORY REQUIREMENTS ON ACCESS AND BENEFIT- SHARING 1. Each Party shall take appropriate, effective and proportionate legislative, administrative or policy measures to provide that genetic resources utilized within its jurisdiction have been accessed in accordance with prior informed consent and that mutually agreed terms have been established, as required by the domestic access and benefit-sharing legislation or regulatory requirements of the other Party. Vague wording, similar obligation as in Art 15.7 Flexibility of the user countries in their choice of implementing Leaves the primary regulatory burden upon provider countries

Observations: Utilisation in context ARTICLE 12 COMPLIANCE WITH DOMESTIC LEGISLATION OR REGULATORY REQUIREMENTS ON ACCESS AND BENEFIT- SHARING [ ] 2. Parties shall take appropriate, effective and proportionate measures to address situations of non-compliance with measures adopted in accordance with paragraph 1. 3. Parties shall, as far as possible and as appropriate, cooperate in cases of alleged violation of domestic access and benefit-sharing legislation or regulatory requirements referred to in paragraph 1. More in detail than Art 15.7, as non-compliance is regulated Potential to create incentives for users to comply Needs implementation for being functional Obligation to cooperate in case violation of domestic ABS

Observations: A side look at the ACTA ARTICLE 6: GENERAL OBLIGATIONS WITH RESPECT TO ENFORCEMENT 1. Each Party shall ensure that enforcement procedures are available under its law so as to permit effective action against any act of infringement of intellectual property rights covered by this Agreement, including expeditious remedies to prevent infringements and remedies which constitute a deterrent to further infringements. [...] Harder language: shall ensure vs shall take appropriate, effective and proportionate legislative, administrative or policy measures

ACTA overview: Injunctions: prompt and effective provisional measures (Art. 12.1) Damages ARTICLE 14: SMALL CONSIGNMENTS AND PERSONAL LUGGAGE [ ] 2. A Party may exclude from the application of this Section small quantities of goods of a non-commercial nature contained in travellers personal luggage. Art. 23.1: Each Party shall provide for criminal procedures and penalties to be applied at least in cases of willful trademark counterfeiting or copyright or related rights piracy on a commercial scale. Comparism: no clear catalogue of remedies in Nag P, no discussion of criminal remedies, even no clear obligation to include an obligation to make mandatory

Special considerations (pathogens) Art. 6 In the development and implementation of its access and benefit-sharing legislation or regulatory requirements, each Party shall: [...] (b) Pay due regard to cases of present or imminent emergencies that threaten or damage human, animal or plant health, as determined nationally or internationally. Parties may take into consideration the need for expeditious access to genetic resources and expeditious fair and equitable sharing of benefits arising out of the use of such genetic resources, including access to affordable treatments by those in need, especially in developing countries. Observations: Relevance for AnGR, threaten to damage... animal... health Call for national and international procedures to determine emergencies Expeditious access and benefit-sharing

Pathogenes: Connections to the patent system: Micro-organisms mandatory subject matter for patents (TRIPS 27) Will also be patentable in source countries and providing countries No exceptions for emergencies Medicines and vaccines for monopoly prices No obligation in the patent system of B.Sh

Typical ABS-situation Pathogenes: Obvious connection between access and benefits arising easily proven Huge need for access also in the future mutations and new lifeforms Imbalanced with patent law: no corresponding exceptions Compulsory licenses is not a relevant tool (ICCs argument: detrimental for biological diversity) Open question how this will be and should be developed further and implemented

Observations: In conclusion: Good flexibility for making AnGR adapted solutions Large discretion for countries in the implementation: lessen the legal functionality Both animals (AnGR) and threats to animal heath are addressed Need for making a Nagoya AnGR Guideline that is a guide for functional national implementation of the Nagoya Protocol with the special aims and needs of the Animal sector

Thanks to: Olivier Rukundo Tomme Young Everyone involved in ABS Capacity Building Project for Africa Morten Walløe Tvedt, mwt@fni.no, www.fni.no Senior Research Fellow, FNI